Promising drug by UAlberta researchers could save millions of lives.
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Heart specialist Gavin Oudit and his research team discovered a molecule—angiotensin converting enzyme 2 (ACE2)—that works to restore balance to the pathways responsible for chronic and acute heart failure, including in patients with advanced heart failure who underwent heart transplants.
In conducting their research, Oudit and his team used genetic mapping technology to discover to an extent not seen before how the renin-angiotensin system (RAS)—which regulates the body’s sodium balance, fluid volume and blood pressure—is at play in both acute and chronic heart failure.
It led to the creation of recombinant human ACE2, a new drug that was manufactured by Apeiron Biologics in collaboration with Oudit. It was bought by GlaxoSmithKline, which recently successfully completed phase II clinical trials that tested for the safety and efficacy of the drug on hundreds of patients. The new drug is expected to be on the market in the next three to five years.
Oudit added that using mapping technology has also made it possible to individualize the dose a patient needs, allowing for a truly personalized treatment plan for heart failure patients in the future. The study also broke ground by showing how ACE2 can be used in heart transplant patients with heart failure.
About six million Canadians will develop heart failure, a common condition that most often happens after the heart has been damaged or weakened by heart attack or stroke. According to the Canadian Heart and Stroke Foundation, the two most common causes of heart failure are heart attacks and high blood pressure. When someone has heart failure, the heart either can’t accept the inflow of blood or pump it out, or both.
“This research is a terrific example of how the university works together synergistically to develop world-class research and translate that into medicines that impact patient outcomes,” added Oudit.
Learn more: New hope for treating heart failure
Receive an email update when we add a new ARTIFICIAL SYNAPSES article.
The Latest on: Heart failure
via Google News
The Latest on: Heart failure
- Eating nuts may slash heart disease risk in diabetics: Study on February 20, 2019 at 2:26 am
Eating a handful of tree nuts daily, such as almonds, walnuts and pistachios, may reduce the risk of cardiovascular disease among people with type 2 diabetes, researchers, including one of Indian orig... […]
- Heart disease is the nation’s number one killer of women on February 19, 2019 at 9:46 pm
Heart disease is the nation’s number one killer of women. New research shows its targeting younger age groups. Researchers at the University of North Carolina School of medicine found that in ... […]
- Push-up ability can determine heart disease risk among men: study on February 19, 2019 at 6:18 pm
A new study indicates that the number of push-ups men can do can determine their risk for heart disease. The study from Harvard looked at the heart health of male firefighters over 10 years. […]
- Men who can do 40 push-ups have lower risk of heart disease, study says on February 19, 2019 at 4:27 pm
(Gray News) – Who knew it was so simple? A new study says the number of push-ups a middle-age man can do may be a good indicator of his risk for heart disease. The data was put together by researchers ... […]
- Eating nuts tied to lower heart disease risk for diabetics on February 19, 2019 at 3:39 pm
(Reuters Health) - People with diabetes who regularly eat nuts may be less likely to develop heart disease than their counterparts who rarely, if ever, consume nuts, a U.S. study suggests. Diabetics w... […]
- Star Jones: I Was the Epitome of Heart Disease and Didn’t Know It on February 19, 2019 at 3:37 pm
The TV personality and heart disease survivor hopes sharing her journey will empower other women to take control of their heart health. Share on Pinterest “Women are used to being the caregivers of th... […]
- Even Well-Treated Heart Failure May Raise Risk for Death After Noncardiac Surgery on February 19, 2019 at 1:26 pm
Although the risk for death after noncardiac surgery is certainly elevated in patients with heart failure (HF) and a low left-ventricular ejection fraction (LVEF), the same applies when LVEF is only m... […]
- Physically active women have significantly decreased risk of heart disease on February 19, 2019 at 12:53 pm
Women who spent less of their day in sedentary behaviors—sitting or reclining while awake—had a significantly decreased risk of heart disease, but there has been an increase in the incidence ... […]
- Study links hormone therapy to increased risk of heart disease on February 19, 2019 at 8:02 am
Hormone therapy during gender transition treatment may carry a much higher risk for developing heart disease, new research warns. The study, conducted by Dutch researchers at Amsterdam University Medi... […]
via Bing News